Literature DB >> 6592118

A 'new' DR4 associated D specificity 'JA' in type 1 (insulin-dependent) diabetes: A9, Bw16, DJA, DR4 haplotype.

A Mustonen, J Ilonen, H M Surcel, H K Akerblom.   

Abstract

The HLA antigen combination A9, Bw16 has been found to be associated with Type 1 (insulin-dependent) diabetes characterized by some special features in Northern Finland. This antigen combination has now been associated with a 'new' DR4-associated D antigen, provisionally called 'JA' or 'SN'. This 'new' D specificity was also associated with HLA-B18. Although the combination, Dw3/DJA, was common in Type 1 diabetic patients, the frequency of the combination Dw4/DJA was decreased compared with the expected value. This supports the hypothesis of two different risk factors associated with DR3 and DR4.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6592118     DOI： 10.1007/bf00275668

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


  10 in total

1.  Stimulatory and cytotoxic activity on human adult and fetal lymphocytes by heterologous antihuman fetal lymphocyte sera.

Authors:  O Turunen; C Lundqvist; M Julin; G Holmlund; A Tiilikainen; A de la Chapelle
Journal:  Transplantation       Date:  1979-05       Impact factor: 4.939

2.  Five HLA-D clusters associated with HLA-DR4.

Authors:  N L Reinsmoen; F H Bach
Journal:  Hum Immunol       Date:  1982-06       Impact factor: 2.850

3.  HLA-A,B,C and haplotype frequencies in the Finnish population.

Authors:  M L Lokki; M Julin
Journal:  Tissue Antigens       Date:  1982-10

Review 4.  The genetic susceptibility to type I (insulin-dependent) diabetes mellitus.

Authors:  A G Cudworth; E Wolf
Journal:  Clin Endocrinol Metab       Date:  1982-07

Review 5.  MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease.

Authors:  M Thomsen; P Platz; O O Andersen; M Christy; J Nerup; K Rasmussen; L P Ryder; L S Nielsen; A Svejgaard
Journal:  Transplant Rev       Date:  1975

Review 6.  Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture.

Authors:  P I Terasaki; D Bernoco; M S Park; G Ozturk; Y Iwaki
Journal:  Am J Clin Pathol       Date:  1978-02       Impact factor: 2.493

7.  An islet cell antibody negative form of insulin-dependent diabetes mellitus (IDD) associated with HLA antigens A9 and Bw16.

Authors:  A Mustonen; J Ilonen; H K Akerblom; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

8.  HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus.

Authors:  P Platz; B K Jakobsen; N Morling; L P Ryder; A Svejgaard; M Thomsen; M Christy; H Kromann; J Benn; J Nerup; A Green; M Hauge
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

9.  Increase of HLA haplotype A9-Bw16 in familial insulin-dependent diabetes mellitus in northern-Finland.

Authors:  J Ilonen; H K Akerblom; A Tiilikainen; A Mustonen; E Herva; S Koskimies; K Kouvalainen
Journal:  Acta Diabetol Lat       Date:  1982 Apr-Jun

10.  HLA genetics of insulin-dependent juvenile-onset diabetes mellitus in northern Finland.

Authors:  J Ilonen; E Herva; A Tiilikainen; H K Akerblom; A Mustonen; T Koivukangas; K Kouvalainen
Journal:  Tissue Antigens       Date:  1980-04
  10 in total
  2 in total

1.  HLA antigens in Spanish type 1 diabetic population. Correlations with clinical, biological and autoimmune markers.

Authors:  A Goday; E Motaña; G Ercilla; J Fernandez; R Gomis; E Vilardell
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

2.  An analysis of epidemiological data in HLA-typed diabetic children.

Authors:  A Mustonen; J Ilonen; A Tiilikainen; M Kataja; H K Akerblom
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.